CVX
47
3
FITB
63
3
LH
43
-2
BMY
60
2
WM
79
3
DRI
53
5
UA
50
-9
MRK
25
-2
RL
72
4
MAS
58
2
PSX
47
2
CMG
72
5
CL
58
2
STI
14
-17
ROK
62
15
KMI
67
-2
UPS
60
9
NWS
66
-3
KMB
39
2
MET
72
5
CVX
47
3
FITB
63
3
LH
43
-2
BMY
60
2
WM
79
3
DRI
53
5
UA
50
-9
MRK
25
-2
RL
72
4
MAS
58
2
PSX
47
2
CMG
72
5
CL
58
2
STI
14
-17
ROK
62
15
KMI
67
-2
UPS
60
9
NWS
66
-3
KMB
39
2
MET
72
5
Financhill
Back

Tandem Diabetes Care Vs. Perspective Therapeutics Industry Stock Comparison

Sell
29

TNDM
Tandem Diabetes Care

Last Price:
30.82
Seasonality Move:
6.87%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
29
Tandem Diabetes Care (TNDM) is a Sell

Is Tandem Diabetes Care a Buy, Sell or Hold?

  • The current Tandem Diabetes Care [TNDM] share price is $30.81. The Score for TNDM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • TNDM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TNDM Stock Price Chart

What is Tandem Diabetes Care's stock price today?

  • The Tandem Diabetes Care share price today is $30.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNDM is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TNDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.78 Sell
Relative Strength Index (14 RSI): 44.7 Sell
Chaikin Money Flow: 350853 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.55 - 33.23) Sell
Bollinger Bands (100): (33.99 - 44.53) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

TNDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.24 Buy
20-day SMA: 31.09 Sell
50-day SMA: 36.34 Sell
200-day SMA: 38.1 Sell
8-day EMA: 30.03 Buy
20-day EMA: 31.29 Sell
50-day EMA: 34.76 Sell
200-day EMA: 36.92 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.51 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Tandem Diabetes Care Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):